Garda Capital Partners’s CVS Health CVS Stock Holding History

Garda Capital Partners’s Portfolio CVS Stock Details CVS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q3	–	Sell	-4,500	Closed	-$266K	–	531
2024 Q2	$266K	Hold	4,500	–	–	0.01%	437
2024 Q1	$359K	Buy	+4,500	New	+$344K	0.02%	353
2023 Q2	–	Sell	-8,000	Closed	-$594K	–	367
2023 Q1	$594K	Sell	8,000 -36,000	-82%	-$3.02M	0.03%	279
2022 Q4	$4.1M	Buy	+44,000	New	+$4.25M	0.23%	133

Other funds holding CVS

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Norges Bank Oslo, Norway $935B AUM

Garda Capital Partners's CVS Position: Q1 2023 in Review

Garda Capital Partners sold out of CVS Health (CVS) in Q1 2023, closing a stake of 12,296 shares — an estimated $1.03M sold.

Garda Capital Partners first reported a position in CVS in Q4 2022 and held it in 1 quarter. The position peaked at $1.15M in Q4 2022. 2,267 funds tracked by Wall St. Rank hold CVS as of Q1 2023.

Garda Capital Partners reported no remaining CVS Health position as of Q1 2023 after selling out during the quarter.
Garda Capital Partners sold 12,296 CVS Health shares in Q1 2023, an estimated $1.03M.
Garda Capital Partners first reported a position in CVS Health in Q4 2022 and held it in 1 quarter.
Garda Capital Partners's CVS Health position peaked at $1.15M in Q4 2022.
2,267 funds tracked by Wall St. Rank held CVS Health as of Q1 2023.

Based on Garda Capital Partners's 13F filing for Q1 2023, filed 10 May 2023.